期刊
MOLECULAR CELL
卷 43, 期 3, 页码 449-463出版社
CELL PRESS
DOI: 10.1016/j.molcel.2011.06.011
关键词
-
资金
- Wilhelm-Sander-Stiftung [2008.072.1]
- Deutsche Forschungsgemeinschaft [Le 953/5-1, Le 953/6-1, Graduiertenkolleg 1167, TP6.1]
- Tetralogics Pharmaceuticals
- MRC [MC_U132685863] Funding Source: UKRI
- Medical Research Council [MC_U132685863] Funding Source: researchfish
The intracellular regulation of cell death pathways by cIAPs has been enigmatic. Here we show that loss of cIAPs promotes the spontaneous formation of an intracellular platform that activates either apoptosis or necroptosis. This 2 MDa intracellular complex that we designate Ripoptosome is necessary but not sufficient for cell death. It contains RIP1, FADD, caspase-8, caspase-10, and caspase inhibitor cFLIP isoforms. cFLIP(L) prevents Ripoptosome formation, whereas, intriguingly, cFLIPs promotes Ripoptosome assembly. When cIAPs are absent, caspase activity is the rheostat that is controlled by cFLIP isoforms in the Ripoptosome and decides if cell death occurs by RIP3-dependent necroptosis or caspase-dependent apoptosis. RIP1 is the core component of the complex. As exemplified by our studies for TLR3 activation, our data argue that the Ripoptosome critically influences the outcome of membrane-bound receptor triggering. The differential quality of cell death mediated by the Ripoptosome may cause important pathophysiological consequences during inflammatory responses.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据